. Show Affiliations »
Abstract
Mesh: See more » AnimalsClinical Trials, Phase III as TopicDrug ApprovalHumansNeuroprotective Agents/therapeutic useStroke/drug therapyTreatment Failure
Substances: See more » Neuroprotective Agents
Year: 2006 PMID: 17084736 DOI: 10.1016/S0140-6736(06)69645-1
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321